BusinessHemispherx Biopharma Announces Extension of Rintatolimod European Early Access Program (EAP) to Pancreatic Cancer PatientsBy Nasdaq OMXJan 11, 2017, 1:31 PM UTC
BusinessAXIM Biotech Attends Biotech Showcase and J.P. Morgan Healthcare Conferences in San FranciscoBy Nasdaq OMXJan 10, 2017, 2:01 PM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Signs Marketing & Media Agreement with Pearls of Health and Appoints Gabriel Aviles as Chief Sales Officer (CSO).By Nasdaq OMXJan 9, 2017, 12:45 PM UTC
BusinessAXIM® Biotech Receives Positive PK Data Results for CanChew Plus® CBD GumBy Nasdaq OMXJan 4, 2017, 2:04 PM UTC
BusinessAXIM® Biotech Receives Positive PK Data Results for CanChew Plus® CBD GumBy Nasdaq OMXJan 4, 2017, 2:03 PM UTC
BusinessAXIM® Biotech Expands Advisory Board to Broaden the Development of Cannabinoids' Therapeutic IndicationsBy Nasdaq OMXDec 29, 2016, 2:00 PM UTC
BusinessEarth Science Tech Engages RedChip to Lead Investor Relations EffortsBy Nasdaq OMXDec 28, 2016, 9:05 PM UTC
BusinessAchillion Announces Clinical Milestone for the Advancement of JNJ-4178 in Phase 2B Development for Chronic HCVBy Nasdaq OMXDec 28, 2016, 11:05 AM UTC
